Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Ulcerative Colitis
Clinical trial register · United Kingdom · industry-sponsored

Ulcerative Colitis Trials in the UK, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 2883 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 28 Oct 2026, 03:15 UTC
2883
Studies in scope
industry-sponsored, all four open statuses
1389
Recruiting now
open to new participants
545
Lead sponsors
across recruiting studies
Top sites
London 22 Cambridge 10 Bury 8 Oxford 7 Glasgow 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie5 Pfizer3 Eli Lilly and Company3 Merck Sharp & Dohme LLC2 Gilead Sciences2
Site city
London22 Cambridge10 Bury8 Oxford7 Glasgow5
All 33 cities
Target enrolment
to

Ulcerative Colitis trials in the UK

25 of 2883 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
UK sites
Start
Active, closed
Pfizer
Observational
4,000
Tadworth
2026-04-01
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Cambridge, Bury, London, Huddersfield
2026-03-24
Recruiting
Sanofi
Phase 3
751
London
2026-01-16
Recruiting
Alfasigma S.p.A.
Phase 3
80
Bristol, Glasgow, Liverpool, London, Sheffield
2025-09-29
Recruiting
Genentech, Inc.
Phase 2
224
London, Liverpool, Oxford, Cambridge
2025-09-29
Recruiting
AbbVie
Phase 3
120
Cambridge, Sheffield, Liverpool
2025-07-28
Active, closed
Sanofi
Phase 2
105
Northwich, Bury, London
2025-07-07
Recruiting
Eli Lilly and Company
Phase 3
350
Bristol, Dundee, Exeter, London
2025-06-26
Active, closed
AbbVie
Phase 3
573
London, North Finchley, Glasgow, Manchester, Oxford, Birmingham, Stockport
2025-06-17
Active, closed
Takeda
Phase 2
213
London, Belfast, Cambridge
2024-03-29
Active, closed
Gilead Sciences
Phase 2
228
Bristol, Bury, Cambridge, Cardiff, London, North Shields
2024-03-27
Active, closed
AbbVie
Phase 2
156
Cambridge, Glasgow, London, Oxford
2024-03-23
Active, closed
Gilead Sciences
Phase 2
176
Bury, Cambridge, London, Norwich, Southampton
2023-12-05
Active, closed
AnaptysBio, Inc.
Phase 2
132
Belfast, Cambridge, Liverpool, London, Runcorn, Shrewsbury, York
2023-12-04
Active, closed
AbbVie
Phase 3
122
Sheffield, London, Southampton, Birmingham
2023-11-06
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Bristol, Cambridge, Exeter, Doncaster, Huddersfield, London, Southampton, West Midlands
2023-10-25
Active, closed
Alfasigma S.p.A.
Observational
509
Belfast, Bury, Exeter, Glasgow, London, Norwich, Oxford, Southampton
2023-06-12
Recruiting
Takeda
Phase 3
240
London, Cardiff, Birmingham, Manchester
2023-05-16
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Cambridge, London, Bury, Harrow, Yeovil, Huddersfield
2023-01-16
Active, closed
AbbVie
Observational
785
Exeter, Hull, Basingstoke, Bury, Kettering, Nottingham, Oxford, Belfast
2022-08-15
Active, closed
Pfizer
Phase 3
118
London, Birmingham
2021-08-12
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
London, Oxford, Sheffield
2021-05-26
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Glasgow, London
2019-09-26
Active, closed
Pfizer
Phase 3
896
London, Yeovil
2019-09-05
Active, closed
Eli Lilly and Company
Phase 3
1,058
Bury, London, Oxford
2018-07-18
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-uk/condition/ulcerative-colitis

Query this register directly
GET /api/trials?country=uk&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the UK and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,883 studies in total at the last sync on 28 Oct 2026, 03:15 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 25 of those studies listing the condition Ulcerative Colitis.

How many Ulcerative Colitis trials are recruiting in the UK?

8 of the 25 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:15 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Ulcerative Colitis), 25 studies
PhaseStudiesRecruitingShare
Phase 313652%
Phase 28232%
Observational3012%
Phase 2/3104%

Most active sponsors

Lead sponsors with the most studies (Ulcerative Colitis)
Lead sponsorStudiesRecruiting
AbbVie51
Eli Lilly and Company32
Pfizer30
Alfasigma S.p.A.21
Gilead Sciences20
Merck Sharp & Dohme LLC21
Sanofi21
Takeda21
Abivax S.A.10
AnaptysBio, Inc.10
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the UK Pharma Salary Guide, or see the Ireland, EU and USA registers.